分子細胞遺傳學市場規模、佔有率及成長分析（按產品、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，分子細胞遺傳學市場價值將達到 26 億美元，到 2025 年將成長至 28.2 億美元，到 2033 年將成長至 55 億美元，在預測期（2026-2033 年）內複合年成長率為 8.7%。

分子細胞遺傳學結合了分子生物學和細胞遺傳學，用於區分正常細胞和癌細胞，從而提高癌症的檢測和治療水平。該領域在染色體異常的研究中發揮關鍵作用，並利用螢光雜合反應（FISH）等技術分析特定的基因組區域。癌症和遺傳疾病發生率的上升以及人口老化是推動該市場發展的主要因素。其主要應用領域包括建立疾病模型和開發標靶治療。此外，試劑、軟體和試劑盒等技術的進步也提高了診斷的準確性和可靠性。對生物醫學研究的持續投入和醫療基礎設施的改善進一步鞏固了該市場的成長勢頭，並滿足了對個人化治療方案和全面患者管理的需求。

分子細胞遺傳學市場促進因素

由於細胞遺傳學和分子生物學的融合，分子細胞遺傳學市場預計將迎來顯著成長。隨著越來越多的研究人員和臨床醫生認知到分子細胞遺傳學在診斷和理解遺傳疾病方面的價值，這一新興領域的需求預計將會增加。此外，癌症發生率的上升預計將進一步推動分子細胞遺傳學技術的應用，這些技術能夠提供關於染色體異常和基因功能的重要資訊。在這些強勁因素的驅動下，隨著技術和調查方法的不斷進步，該市場有望實現顯著擴張。

分子細胞遺傳學市場限制因素

分子細胞遺傳學市場面臨的主要挑戰之一是不利的報銷政策，這嚴重阻礙了市場成長。保險公司往往不願意承擔分子診斷檢測的相關費用，這給尋求這些必要服務的患者設置了障礙。此外，基因檢測的高昂費用（單次檢測通常高達約300美元）進一步限制了患者獲得這些重要技術的機會。由於分子診斷對於早期發現和干涉至關重要，其高昂的費用和缺乏保險支持對分子細胞遺傳學的廣泛應用和發展構成了重大障礙。

分子細胞遺傳學市場趨勢

受腫瘤學領域對個人化醫療日益重視的推動，分子細胞遺傳學市場正經歷顯著成長。深入了解基因組對於提高癌症診斷準確性和製定個人化治療策略至關重要。腫瘤學正逐漸成為分子細胞遺傳學的關鍵應用領域，因為該方法已被證明在治療方法選擇、預後預測和復發風險評估方面發揮關鍵作用。此外，向個人化治療和藥物療法的轉變預計將進一步推動市場擴張。這一趨勢反映了人們致力於透過先進的基因組學見解來改善患者預後並革新癌症治療通訊協定的廣泛努力。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究
• 專利分析

全球分子細胞遺傳學市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 試劑盒和試劑
  • 檢測套組
  • 探測
  • 螢光親和性和試劑
  • 其他試劑盒和試劑
• 裝置
• 消耗品
• 軟體和服務

全球分子細胞遺傳學市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 比較基因組雜合反應
  • 基於晶片的比較基因組雜合反應
  • 標準比較基因組雜合反應
• 螢光原位雜合反應
• 顯色原位雜合反應
• 核型分析
  • 頻譜
  • 虛擬性
• 其他技術

全球分子細胞遺傳學市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 遺傳性疾病
• 癌症
• 個人化醫療
• 其他用途

全球分子細胞遺傳學市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 臨床和研究檢查室
• 醫院/病理檢查室
• 學術研究機構
• 製藥和生物技術公司
• 其他最終用戶

全球分子細胞遺傳學市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• F. Hoffmann-la roche ltd.
• Agilent technologies, inc.
• Abbott laboratories
• Thermo fisher scientific, inc.
• Illumina inc.
• Revvity
• Pacific biosciences
• Bio-rad laboratories, inc.
• Bio-techne corporation
• Genedx
• Bioview
• Applied spectral imaging, inc.
• Cytotest inc.
• Kromatid, inc.
• Genial genetic solutions ltd.
• Cytognomix, inc.
• Metasystems
• Scigene
• Biomodal
• Biocare medical

結論與建議

Molecular Cytogenetics Market size was valued at USD 2.6 Billion in 2024 and is poised to grow from USD 2.82 Billion in 2025 to USD 5.5 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

Molecular cytogenetics combines molecular biology and cytogenetics to distinguish between healthy and cancerous cells, enhancing cancer detection and treatment. This field plays a vital role in studying chromosomal abnormalities and utilizes techniques like fluorescence in situ hybridization (FISH) to analyze specific genomic regions. The market is significantly driven by the rising prevalence of cancer and genetic disorders, coupled with an aging population. Its primary applications include establishing disease models and developing targeted therapies. Additionally, advancements in technology, such as improved reagents, software, and kits, contribute to enhanced diagnostic accuracy and reliability. The ongoing investment in biomedical research and improvements in healthcare infrastructure further solidify the market's growth trajectory, supporting the need for tailored treatment options and comprehensive patient management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Molecular Cytogenetics Market Segments Analysis

Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Molecular Cytogenetics Market

The molecular cytogenetics market is poised for significant growth, fueled by the integration of cytogenetics with molecular biology. This burgeoning field is expected to witness an increase in demand as more researchers and clinicians recognize its value in diagnosing and understanding genetic disorders. Additionally, the rising incidence of cancer is anticipated to further boost the adoption of molecular cytogenetics techniques, as they provide essential insights into chromosomal abnormalities and gene functions. As advancements in technology and methodologies continue to evolve, the market is likely to experience substantial expansion, driven by these compelling factors.

Restraints in the Molecular Cytogenetics Market

One of the key challenges facing the Molecular Cytogenetics market is the presence of unfavorable reimbursement policies, which significantly hinder its growth. Insurance providers are often reluctant to cover the costs associated with molecular diagnostic tests, creating barriers for patients seeking these essential services. Additionally, the high expense of genetic testing, which often reaches approximately USD 300 per test, further restricts access to these vital technologies. As molecular diagnostics are crucial for early detection and intervention, their elevated costs and lack of insurance support pose a considerable obstacle to the broader adoption and advancement of molecular cytogenetics.

Market Trends of the Molecular Cytogenetics Market

The market for Molecular Cytogenetics is witnessing significant growth, driven by the increasing emphasis on personalized medicine in oncology. A thorough understanding of genomes is becoming integral to cancer care, enhancing diagnostic precision and tailoring therapeutic strategies. As molecular cytogenetic techniques prove paramount in determining treatment options, predicting outcomes, and assessing recurrence risks, oncology emerges as the dominant application area. Additionally, the transition toward individualized therapies and pharmacotherapy is anticipated to further stimulate market expansion. This trend reflects a broader commitment to improving patient outcomes and revolutionizing cancer treatment protocols through advanced genomic insights.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Global Molecular Cytogenetics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

Global Molecular Cytogenetics Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence In-Situ Hybridization
• Chromogenic In-Situ Hybridization
• Karyotyping
  • Spectral
  • Virtual
• Other Techniques

Global Molecular Cytogenetics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

Global Molecular Cytogenetics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Clinical & Research Laboratories
• Hospitals & Path Labs
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Molecular Cytogenetics Market Size & CAGR (2026-2033)

• North America (Product, Technique, Application, End User)
  • USA
  • Canada
• Europe (Product, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technique, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-la roche ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent technologies, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo fisher scientific, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-rad laboratories, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-techne corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioview
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied spectral imaging, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytotest inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kromatid, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genial genetic solutions ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytognomix, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metasystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scigene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomodal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations